Clinically, high serum GDF15 levels were significantly associated with advanced age, late TNM stage, and elevated CEA, indicating its correlation with aggressive disease features.<h4>Conclusion</h4>Our findings demonstrate that GDF15 acts as a tumor promoter in CRC by driving EMT, facilitating proliferation and metastasis, and enhancing cancer stemness. Here, GDF15 is linked to cancer.